These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8256114)

  • 21. Mycobacteria induce CD4+ T cells that are cytotoxic and display Th1-like cytokine secretion profile: heterogeneity in cytotoxic activity and cytokine secretion levels.
    Mutis T; Cornelisse YE; Ottenhoff TH
    Eur J Immunol; 1993 Sep; 23(9):2189-95. PubMed ID: 8103743
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Bezerra-Santos M; do Vale-Simon M; Barreto AS; Cazzaniga RA; de Oliveira DT; Barrios MR; Ferreira AR; Santos-Bio NC; Reed SG; de Almeida RP; Corrêa CB; Duthie MS; de Jesus AR
    Front Immunol; 2018; 9():2920. PubMed ID: 30631322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Mycobacterium leprae on lymphocyte proliferation: suppression of mitogen and antigen responses of human peripheral blood mononuclear cells.
    Touw J; Stoner GL; Belehu A
    Clin Exp Immunol; 1980 Sep; 41(3):397-405. PubMed ID: 6449337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
    Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
    Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients.
    Launois P; Huygen K; De Bruyn J; N'Diaye M; Diouf B; Sarthouj L; Grimaud J; Millan J
    Clin Exp Immunol; 1991 Nov; 86(2):286-90. PubMed ID: 1934596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type 1- and type 2-like lesional skin-derived Mycobacterium leprae-responsive T cell clones are characterized by coexpression of IFN-gamma/TNF-alpha and IL-4/IL-5/IL-13, respectively.
    Verhagen CE; van der Pouw Kraan TC; Buffing AA; Chand MA; Faber WR; Aarden LA; Das PK
    J Immunol; 1998 Mar; 160(5):2380-7. PubMed ID: 9498780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium leprae-specific Lyt-2+ T lymphocytes with cytolytic activity.
    Chiplunkar S; De Libero G; Kaufmann SH
    Infect Immun; 1986 Dec; 54(3):793-7. PubMed ID: 3096892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
    Macfarlane A; Mondragon-Gonzalez R; Vega-Lopez F; Wieles B; de Pena J; Rodriguez O; Suarez y de la Torre R; de Vries RR; Ottenhoff TH; Dockrell HM
    Clin Diagn Lab Immunol; 2001 May; 8(3):604-11. PubMed ID: 11329466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of intracellular cytokines in CD4 and CD8 T cells from patients with mycobacterial infections.
    Antas PR; Sales JS; Pereira KC; Oliveira EB; Cunha KS; Sarno EN; Sampaio EP
    Braz J Med Biol Res; 2004 Aug; 37(8):1119-29. PubMed ID: 15273814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of antigen-specific CD4+ HLA-DR-restricted cytotoxic T lymphocytes as well as nonspecific nonrestricted killer cells by the recombinant mycobacterial 65-kDa heat-shock protein.
    Ab BK; Kiessling R; Van Embden JD; Thole JE; Kumararatne DS; Pisa P; Wondimu A; Ottenhoff TH
    Eur J Immunol; 1990 Feb; 20(2):369-77. PubMed ID: 1690136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limiting dilution analysis in leprosy.
    Mullins RJ; Roche P; Adams E; Jones P; Chen S; Theuvenet W; Basten A
    Immunol Cell Biol; 1992 Aug; 70 ( Pt 4)():277-90. PubMed ID: 1427986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals.
    Desai SD; Birdi TJ; Antia NH
    Infect Immun; 1989 Apr; 57(4):1311-7. PubMed ID: 2494115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphocyte response of leprosy patients to human-derived and purified armadillo-derived Mycobacterium leprae, BCG and PPD.
    Smelt AH; Liew FY; Rees RJ
    Clin Exp Immunol; 1978 Nov; 34(2):164-9. PubMed ID: 367652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.
    Nath I; Singh R
    Clin Exp Immunol; 1980 Sep; 41(3):406-14. PubMed ID: 7002396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility to Mycobacterium leprae of ALY (alymphoplasia) mice and IFN-gamma induction in the culture supernatant of spleen cells.
    Yogi Y; Endoh M; Banba T; Okamura H; Nomaguchi H
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):464-74. PubMed ID: 10347567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy.
    Geluk A; Bobosha K; van der Ploeg-van Schip JJ; Spencer JS; Banu S; Martins MV; Cho SN; Franken KL; Kim HJ; Bekele Y; Uddin MK; Hadi SA; Aseffa A; Pessolani MC; Pereira GM; Dockrell HM; Ottenhoff TH
    J Immunol; 2012 May; 188(10):4782-91. PubMed ID: 22504648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective correlation of interferon-gamma, tumour necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor with immunoglobulin G1 and immunoglobulin G3 subclass antibody in leprosy.
    Hussain R; Kifayet A; Dojki M; Dockrell HM
    Immunology; 1999 Oct; 98(2):238-43. PubMed ID: 10540222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro stimulation of lymphocytes in leprosy patients, healthy contacts of leprosy patients, and subjects not exposed to leprosy. Comparison of an antigen fraction prepared from Mycobacterium leprae and tuberculin-purified protein derivative.
    Closs O; Reitan LJ; Negassi K; Harboe M; Belehu A
    Scand J Immunol; 1982 Aug; 16(2):103-15. PubMed ID: 6182610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interruption of persistent exposure to leprosy combined or not with recent BCG vaccination enhances the response to Mycobacterium leprae specific antigens.
    de Carvalho FM; Rodrigues LS; Duppre NC; Alvim IMP; Ribeiro-Alves M; Pinheiro RO; Sarno EN; Pessolani MCV; Pereira GMB
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005560. PubMed ID: 28467415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.